Minute Insight: Tasso Raises $100M In Series B To Scale Manufacturing Of At-Home Blood Collection Devices
Executive Summary
Tasso, which developed devices that allow patients to draw blood samples at home, wants to transform health care by supporting decentralized clinical trials, clinical research and remote patient health monitoring.